ReWalk
ReWalk, OurCrowd’s first Initial Public Offering, is the most studied exoskeleton technology in the world, with the most published data of any exoskeleton. It is the first exoskeleton available for personal use.
ReWalk went public on NASDAQ (RWLK) on Friday, September 12, 2014 at $12, below the range of $15-17/share. Over the weekend, it rose over 100% to the $25-27/share range.
ReWalk was the first IPO since 2000 to price below its range and to rise over 100% in 48 hours. It was also the first early stage company to crowdfund and then go public.
Founded in 2001, ReWalk Robotics is a global company with headquarters in the US, Germany, and Israel. ReWalk Robotics develops, manufactures and markets wearable robotic exoskeletons for people with lower limb disabilities, such as paraplegia. ReWalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury.
The ReWalkâ„¢ exoskeleton suit was developed by Dr. Amit Goffer, an Israeli inventor who became quadriplegic after an ATV accident in 1997. It was through his own personal experience in utilizing mobility devices for people with spinal cord injury that Dr. Goffer developed the ReWalk.
ReWalk uses patented technology with motorized legs that power knee and hip movement. Battery-powered for all-day use, ReWalk is controlled by on-board computers and motion sensors, restoring self-initiated walking without needing tethers or switches to begin stepping.
ReWalk controls movement using subtle changes in center of gravity, mimics the natural gait pattern of the legs similar to that of an able-bodied person, and provides functional walking speed. A forward tilt of the upper body is sensed by the system, which triggers the first step.
ReWalk is the only exoskeleton with FDA clearance via clinical studies and extensive performance testing for personal use.
Company website: www.rewalk.com
